39
Participants
Start Date
December 31, 2011
Primary Completion Date
November 30, 2019
Study Completion Date
November 30, 2019
LDE225; Fluorouracil; Leucovorin; Oxaliplatin; Irinotecan
LDE225 200-800 mg daily orally. Fluorouracil 2400 mg IV every other week. Irinotecan 180 mg/m2 IV every other week. Oxaliplatin 85 mg/m2 IV every other week. Leucovorin 400 mg/m2 IV every other week.
Massachusetts General Hospital, Boston
Dana-Farber Cancer Institute, Boston
Dana-Farber Cancer Institute
OTHER
Massachusetts General Hospital
OTHER